Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
01-Sep-2025 to
03-Sep-2025
Issue Size
₹126 Cr
Price Band
₹120 to ₹126
Allotment date
04-Sep-2025
Listing date
09-Sep-2025
Lot size
119
No. of shares
1,00,00,000
Fresh issue/OFS
₹126 Cr /--
Amanta Healthcare Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of sterile liquid products, with a focus on parenteral formulations. The company specializes in large volume parenterals (LVPs) and small volume parenterals (SVPs) using advanced aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. Its product portfolio spans fluid therapy, diluents, ophthalmic care, respiratory solutions, and irrigation products, alongside medical devices such as first-aid solutions and eye lubricants. With operations segmented into national sales, international sales, and product partnering, Amanta caters to domestic and global markets, exporting to over 20 countries and maintaining regulatory approvals across multiple jurisdictions.
Category
Status
QIBs
35.9x
NIIs
209.4x
Retail
54.8x
Others
--
Total
82.5x
The issue size of Amanta Healthcare is ₹126.00 Cr.
Amanta Healthcare falls into Healthcare & Services industry.
The Amanta Healthcare IPO will be listed on both NSE and BSE.
The open and close dates for the Amanta Healthcare are 01-Sep-2025 & 03-Sep-2025.
The price band for the Amanta Healthcare ipo is ₹120 to ₹126
The listing date of Amanta Healthcare IPO is 09-Sep-2025.
The purpose of this IPO is to raise fresh capital.
Amanta Healthcare total subscription ratio is 82.5X.
Key financial of the Amanta Healthcare are:
| Amanta Healthcare | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 274.71 | 280.34 | 259.13 |
| EBIT (₹ Cr) | 41.27 | 37.76 | 32.55 |
| Proft after Tax (₹ Cr) | 10.5 | 3.63 | -2.11 |
| Debt (₹ Cr) | 195 | 205.23 | 215.66 |
| Net Worth (₹ Cr) | 96.39 | 66.29 | 62.88 |
| RoE (%) | 10.89 | 5.48 | -3.36 |